Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"

Circ Res. 2020 Jun 5;126(12):e142-e143. doi: 10.1161/CIRCRESAHA.120.317242. Epub 2020 Jun 4.

Peng Zhang^{1

2

3}, Lihua Zhu^{1

3}, Jingjing Cai⁴, Fang Lei³, Juan-Juan Qin^{1

3}, Yibin Wang⁵, Yufeng Yuan⁶, Loomba Rohit⁷, Peter P Liu⁸, Hongliang Li^{1

2

3}

¹ From the Department of Cardiology, Renmin Hospital of Wuhan University, China (P.Z., L.Z., J.-J.Q., H.L.).
² Medical Science Research Center (P.Z., H.L.).
³ Institute of Model Animal of Wuhan University, China (P.Z., L.Z., F.L., J.-J.Q., H.L.).
⁴ Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China (J.C.).
⁵ Department of Anesthesiology, Cardiovascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles (Y.W.).
⁶ Department of Hepatobiliary and Pancreatic Surgery (Y.Y.), Zhongnan Hospital of Wuhan University, China.
⁷ NAFLD Research Center, Division of Gastroenterology and Epidemiology, University of California San Diego (L.R.).
⁸ Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, ON, Canada (P.P.L.).

No abstract available

Publication types